Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics …………… Huang Y. Mol Ther Nucleic Acids. 2017 Mar 17;6:116-132. PubMed 00
Ribonucleic artefacts: are some extracellular RNA discoveries driven by cell culture medium components?
Ribonucleic artefacts: are some extracellular RNA discoveries driven by cell culture medium components? …………… Tosar JP, Cayota A, Eitan E, Halushka MK, Witwer KW. J Extracell Vesicles. 2017 Jan 12;6(1):1272832. PubMed 00
2017 Dr. Alan M. Gewirtz Memorial Scholarship Winner: Karyn Schmidt, PhD
Inhibiting the Androgen Receptor Interaction with the Long Non-Coding RNA SLNCR using 2’-FANA-Modified Oligonucleotides Decreases Melanoma Invasion […]
Interview with Thorleif Møller
ThorleifMøller, PhD Mirrx Therapeutics A/S CEO & Founder How did you become interested in the field of oligonucleotides? During my PhD studies at the